NNENNA EMELLE: Open Payments
NPI 1770934127 · AUBURNDALE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$547 in 7 payments from 7 companies in 2025. Trend: 2023 $108 · 2024 $919 · 2025 $547
Food & beverage: $547
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $121 |
| Dexcom, Inc. | 1 | $107 |
| Boston Scientific Corporation | 1 | $102 |
| EVOKE PHARMA, INC. | 1 | $81 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $79 |
| Novo Nordisk Inc | 1 | $32 |
| Janssen Scientific Affairs, LLC | 1 | $25 |
Products named: BREZTRI, DEXCOM G7 GSS (161), WATCHMAN FLX, GIMOTI, LifeVest, Ozempic, INVEGA SUSTENNA.
Industry payments across FL — which companies pay providers there.
